Literature DB >> 21839769

Novel hybrid scaffolds for the cultivation of osteoblast cells.

Hilal Turkoglu Sasmazel1.   

Abstract

In this study, natural biodegradable polysaccharide, chitosan, and synthetic biodegradable polymer, poly(ɛ-caprolactone) (PCL) were used to prepare 3D, hybrid polymeric tissue scaffolds (PCL/chitosan blend and PCL/chitosan/PCL layer by layer scaffolds) by using the electrospinning technique. The hybrid scaffolds were developed through HA addition to accelerate osteoblast cell growth. Characteristic examinations of the scaffolds were performed by micrometer, SEM, contact angle measurement system, ATR-FTIR, tensile machine and swelling experiments. The thickness of all electrospun scaffolds was determined in the range of 0.010±0.001-0.012±0.002 mm. In order to optimize electrospinning processes, suitable bead-free and uniform scaffolds were selected by using SEM images. Blending of PCL with chitosan resulted in better hydrophilicity for the PCL/chitosan scaffolds. The characteristic peaks of PCL and chitosan in the blend and layer by layer nanofibers were observed. The PCL/chitosan/PCL layer by layer structure had higher elastic modulus and tensile strength values than both individual PCL and chitosan structures. The layer by layer scaffolds exhibited the PBS absorption values of 184.2; 197.2% which were higher than those of PCL scaffolds but lower than those of PCL/chitosan blend scaffolds. SaOs-2 osteosarcoma cell culture studies showed that the highest ALP activities belonged to novel PCL/chitosan/PCL layer by layer scaffolds meaning better cell differentiation on the surfaces.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21839769     DOI: 10.1016/j.ijbiomac.2011.07.022

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  7 in total

1.  In vitro osteoclast-like and osteoblast cells' response to electrospun calcium phosphate biphasic candidate scaffolds for bone tissue engineering.

Authors:  I Wepener; W Richter; D van Papendorp; A M Joubert
Journal:  J Mater Sci Mater Med       Date:  2012-09-11       Impact factor: 3.896

2.  Electrospun hydroxyapatite-containing chitosan nanofibers crosslinked with genipin for bone tissue engineering.

Authors:  Michael E Frohbergh; Anna Katsman; Gregory P Botta; Phillip Lazarovici; Caroline L Schauer; Ulrike G K Wegst; Peter I Lelkes
Journal:  Biomaterials       Date:  2012-09-27       Impact factor: 12.479

3.  Osteoblast biocompatibility of premineralized, hexamethylene-1,6-diaminocarboxysulfonate crosslinked chitosan fibers.

Authors:  Marjorie A Kiechel; Laura T Beringer; Amalie E Donius; Yuko Komiya; Raymond Habas; Ulrike G K Wegst; Caroline L Schauer
Journal:  J Biomed Mater Res A       Date:  2015-03-30       Impact factor: 4.396

Review 4.  In vitro three-dimensional cell cultures for bone sarcomas.

Authors:  Javier Munoz-Garcia; Camille Jubelin; Aurélie Loussouarn; Matisse Goumard; Laurent Griscom; Axelle Renodon-Cornière; Marie-Françoise Heymann; Dominique Heymann
Journal:  J Bone Oncol       Date:  2021-07-06       Impact factor: 4.072

5.  Functional enhancement of chitosan and nanoparticles in cell culture, tissue engineering, and pharmaceutical applications.

Authors:  Wenjuan Gao; James C K Lai; Solomon W Leung
Journal:  Front Physiol       Date:  2012-08-21       Impact factor: 4.566

6.  Influence of PLLA/PCL/HA Scaffold Fiber Orientation on Mechanical Properties and Osteoblast Behavior.

Authors:  Lilian de Siqueira; Nilza Ribeiro; Maria B A Paredes; Liliana Grenho; Cassilda Cunha-Reis; Eliandra S Trichês; Maria H Fernandes; Susana R Sousa; Fernando J Monteiro
Journal:  Materials (Basel)       Date:  2019-11-24       Impact factor: 3.623

7.  Amine Plasma-Polymerization of 3D Polycaprolactone/β-Tricalcium Phosphate Scaffold to Improving Osteogenic Differentiation In Vitro.

Authors:  Hee-Yeon Kim; Byung-Hoon Kim; Myung-Sun Kim
Journal:  Materials (Basel)       Date:  2022-01-04       Impact factor: 3.623

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.